Ozawa et al. (21) used combination gene therapy with HGF and t-TGF-βRII for rat liver cirrhosis following partial hepatectomy and suggested that gene therapy may increase the possibility of hepatectomy in a cirrhotic liver by improving fibrosis, hepatic function, and hepatocyte regeneration. Here, TBXT is linked to cirrhosis of liver.